Ionis Pharmaceuticals Inc at Citi BioPharma Conference Transcript
David Lebowitz. I am one of the biotech analysts here at Citi. And thank you for attending the Citi 18th Annual Biopharma Conference. Happy to have on stage with me from Ionis from warm San Diego. Oh, it's pretty warm here today as well, actually. I guess if you could start by introducing yourselves and then maybe walk through the top-level mission of Ionis and the technology behind that mission.
Sure. Happy to. Thank you for having us, David. I'm Beth Hougen, Ionis' Chief Financial Officer, and I've been with the company now for over 23 years. So I'm looking forward to talking a bit more about Ionis today because we really are in the midst of an important transformation for the company.
And I'm Wade Walke, I'm the Head of Investor Relations.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |